Raison C

Department of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA.

3 papers · 2 preprints

ArticlePsychedelics

Well-being as a primary endpoint in clinical trials: a call for consensus.

Marseille E, Kettner H, Sgambati TJ +6

Europe PMC2026
PreprintPsilocybin

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study

Zarrabi AJ, Mletzko T, Grant G +13

Europe PMC2026
ArticlePsychedelics

Health-related behavioral changes following the use of psychedelics in naturalistic settings.

Teixeira PJ, Jain R, Penn AD +5

Europe PMC2025
ArticlePsilocybin

Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.

Herrmann Z, Levin AW, Cole SP +7

Europe PMC2023
PreprintPsilocybin

Psilocybin desynchronizes brain networks

Siegel JS, Subramanian S, Perry D +18

Europe PMC2023